| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡ |
|
| 2027 | ‡‡‡ |
|
| 2026 | 0.40 |
—
—
—
|
| 2025 | 0.36 |
—
—
—
—
|
| 2024 | 0.28 |
—
—
—
—
|
| 2023 | 0.28 |
—
—
—
—
|
| 2022 | 0.07 |
—
|
| 2021 | ‡‡‡ |
|
| 2020 | 0.22 |
—
—
|
| 2019 | 1.32 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2018 | 1.32 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2017 | 1.32 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2016 | 1.30 |
—
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 85.75 | 29.84 | 32.64 | 19.33 |
| Receivables | 4.38 | 2.92 | 2.83 | 2.97 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 90.12 | 32.77 | 35.47 | 22.30 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 29.26 | 29.62 | 26.65 | 31.11 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 29.26 | 29.62 | 26.65 | 31.11 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 67.50 | 87.80 | — | — |
—
|
| ’25 | 68.64 | 80.29 | 78.41 | 67.74 |
295.08
|
| ’24 | 68.44 | 86.48 | 87.18 | 75.11 |
317.21
|
| ’23 | 67.61 | 84.48 | 86.74 | 72.28 |
311.11
|
| ’22 | 54.89 | 81.76 | 87.89 | 70.32 |
294.85
|
| ’21 | 32.11 | 50.24 | 64.30 | 57.32 |
203.98
|
| ’20 | 60.21 | 20.17 | 34.97 | 29.57 |
144.92
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 13.34 | 25.60 | — | — |
—
|
| ’25 | 4.19 | 22.06 | 25.57 | 12.25 |
64.08
|
| ’24 | 6.89 | 25.18 | 28.82 | 12.94 |
73.83
|
| ’23 | 4.75 | 27.99 | 33.58 | 10.12 |
76.44
|
| ’22 | (4.17) | 25.89 | 28.81 | 21.01 |
71.54
|
| ’21 | (12.07) | 9.91 | 20.58 | 10.36 |
28.78
|
| ’20 | (2.86) | (12.88) | 2.99 | (7.21) |
(19.96)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (85.16) | 18.25 | — | — |
—
|
| ’25 | 26.95 | 35.82 | 21.58 | 25.20 |
109.55
|
| ’24 | 13.72 | (26.96) | 22.70 | 35.89 |
45.36
|
| ’23 | (3.35) | 20.49 | 27.75 | 3.44 |
48.33
|
| ’22 | (39.32) | 100.12 | 25.86 | 17.73 |
104.39
|
| ’21 | (13.19) | 6.82 | (51.78) | 6.08 |
(52.06)
|
| ’20 | (8.97) | (17.19) | (0.49) | 56.66 |
30.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.13) | 0.13 | — | — |
—
|
| ’25 | (0.01) | 0.07 | 0.03 | 0.05 |
0.14
|
| ’24 | (0.15) | 0.10 | 0.05 | (0.08) |
(0.08)
|
| ’23 | (0.14) | 0.15 | 0.11 | (0.23) |
(0.11)
|
| ’22 | (0.23) | 0.15 | 0.21 | (0.08) |
0.04
|
| ’21 | 0.06 | (0.18) | (0.07) | (0.27) |
(0.46)
|
| ’20 | (0.59) | (0.57) | (0.38) | (0.07) |
(1.62)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 9.59 | 8.92 | 7.60 | 5.83 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.12 | 14.38 | 11.10 | 8.98 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 17 | 17 | 17 | 16 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.34 | 18.30 | 18.66 | 18.44 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 294.85 | 311.11 | 317.21 | 295.08 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.99% | 55.31% | 54.45% | 54.69% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.87 | 2.49 | 4.04 | 15.31 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.35% | 0.80% | 1.27% | 5.19% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.87 | 2.49 | 4.04 | 15.31 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 60.81 | 59.46 | 62.10 | 61.22 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.04 | 6.37 | 6.49 | 6.05 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.04 | (0.11) | (0.08) | 0.14 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.47 | 1.56 | 1.51 | 1.31 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.67 | (0.58) | (0.58) | 0.93 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.14 | 0.99 | 0.93 | 2.25 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.76 | 16.47 | 16.20 | 15.95 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 48.80 | 48.85 | 48.90 | 48.79 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 235.20 | 0.00 | 0.00 | 48.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.95 | 1.71 | 1.38 | 1.13 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.70 | 0.66 | 0.55 | 0.43 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.65 | 2.71 | 2.13 | 1.50 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.32 | 17.42 | 14.93 | 4.04 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 71.54 | 76.44 | 73.83 | 64.08 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.86 | (28.11) | (28.47) | 45.48 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 104.39 | 48.33 | 45.36 | 109.55 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.80 | 60.87 | 3.14 | 8.82 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 548.55 | 394.54 | 267.21 | 141.48 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 503.40 | 308.80 | 237.37 | 108.84 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 818.00 | 804.38 | 792.00 | 778.05 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.13% | (0.39%) | (0.29%) | 0.59% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.72% | 1.61% | 2.02% | 2.88% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.23% | (0.65%) | (0.47%) | 0.90% | — | — | — |
ROE
|
Chatham Lodging Trust (CLDT), a REIT focused on upscale extended-stay and premium hotels in major U.S. markets, endured a brutal 78% revenue plunge to $145 million in 2020 amid COVID lockdowns, with EPS flipping to -$1.62 and EBT losses ballooning -509%. Recovery has been robust yet incomplete: revenue doubled to $295 million in 2022 and stabilized at $317 million in 2024 (up 2% YoY), gross margins rebounding to 54.5%, and FCF per share reaching $0.93. Stock prices, down ~70% from 2017 peaks, now hover around recent highs of $11 amid imperfect alignment with sales recovery, pressured by high rates.
A standout strength is aggressive deleveraging, slashing total debt 57% to $267 million and net debt 56% to $237 million since 2020, boosting ROIC to 2% and compressing EV/Sales to 2.1x from 7.2x. Valuation screams cheap at 1.4x PS, 0.55x PB, and 15x EV/FCF, far below historical 2.5-3x PS during peak earnings. Yet shares outstanding rose 28% since 2016, and EBT margins linger at a thin 1.3%.
Analysts forecast flat-to-modest revenue ($295-301 million through 2027, down 7% initially), persistent negative EPS (-$0.05 to -$0.14), and 13% average price upside, hinging on Fed rate cuts and hotel cycle revival in Sunbelt/extended-stay niches. With no insider trades and suspended dividends, CLDT offers speculative value for patient investors eyeing occupancy/RevPAR tailwinds, but recession risks loom—positioned better than 2020 lows thanks to a cleaner balance sheet.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.